• 1. Bespoke Gene Therapy Consortium - National Institutes of Health …

  nih.gov

  Link: https://www.nih.gov/research-training/accelerating-medicines-partnership-amp/bespoke-gene-therapy-consortium

  Description: WEBJun 13, 2023 · The AMP Bespoke Gene Therapy Consortium (BGTC) aims to develop platforms and standards that will speed the development and delivery of customized or ‘bespoke’ gene therapies that could treat the millions of people affected by rare diseases.

  DA: 90 PA: 97 MOZ Rank: 10

• 2. NIH, FDA and 15 private organizations join forces to increase …

  nih.gov

  Link: https://www.nih.gov/news-events/news-releases/nih-fda-15-private-organizations-join-forces-increase-effective-gene-therapies-rare-diseases

  Description: WEBThe newly launched Bespoke Gene Therapy Consortium (BGTC), part of the NIH Accelerating Medicines Partnership (AMP) program and project-managed by the Foundation for the National Institutes of Health (FNIH), aims to optimize and streamline the gene therapy development process to help fill the unmet medical needs of people with …

  DA: 89 PA: 19 MOZ Rank: 47

• 3. AMP® Bespoke Gene Therapy Consortium (BGTC) | FNIH

  fnih.org

  Link: https://fnih.org/our-programs/accelerating-medicines-partnership-amp/bespoke-gene-therapy-consortium-bgtc/

  Description: WEBOur mission is to streamline regulatory frameworks to accelerate gene therapies for rare diseases. The Accelerating Medicines Partnership® (AMP®) Program Bespoke Gene Therapy Consortium (AMP BGTC) brings together partners from the public, private, and non-profit sectors to foster development of gene therapies intended to treat rare genetic ...

  DA: 29 PA: 91 MOZ Rank: 47

• 4. FDA, NIH, and 15 private organizations join forces to increase

  fda.gov

  Link: https://www.fda.gov/news-events/press-announcements/fda-nih-and-15-private-organizations-join-forces-increase-effective-gene-therapies-rare-diseases

  Description: WEBOct 27, 2021 · The newly launched Bespoke Gene Therapy Consortium (BGTC), part of the NIH Accelerating Medicines Partnership (AMP) program and project-managed by the Foundation for the National...

  DA: 1 PA: 56 MOZ Rank: 25

• 5. Bespoke Gene Therapy Consortium (BGTC) | National Center for …

  nih.gov

  Link: https://ncats.nih.gov/research/research-activities/BGTC

  Description: WEBExplore BGTC, an innovative program by NCATS driving advancements in gene therapy research. Learn how collaborative efforts are accelerating the development of cutting-edge therapies to address genetic diseases and improve health solutions.

  DA: 58 PA: 35 MOZ Rank: 57

• 6. The Bespoke Gene Therapy Consortium: facilitating development …

  nature.com

  Link: https://www.nature.com/articles/d41573-024-00020-8

  Description: WEBFeb 6, 2024 · The BGTC is a pioneering public–private partnership focused on rare diseases that currently lack commercial interest. By de-risking the basic biology, manufacturing, and preclinical and clinical...

  DA: 29 PA: 24 MOZ Rank: 64

• 7. ASGCT Joins National Partnership to Accelerate Gene Therapy …

  asgct.org

  Link: https://asgct.org/publications/news/october-2021/bespoke-gene-therapy-consortium-announcement

  Description: WEBOct 27, 2021 · The BGTC is the latest initiative to emerge from the Accelerating Medicines Partnership® (AMP®) Program, a public-private collaboration among the NIH, the FDA, the pharmaceutical industry, patient organizations, and other stakeholders to speed drug development across different diseases.

  DA: 22 PA: 36 MOZ Rank: 63

• 8. Partnership to Expand Effective Gene Therapies for Rare Diseases

  nih.gov

  Link: https://directorsblog.nih.gov/2021/11/02/partnership-to-expand-effective-gene-therapies-for-rare-diseases/

  Description: WEBNov 2, 2021 · One way to do things differently—and more efficiently—is the recently launched Bespoke Gene Therapy Consortium (BGTC). It is a bold partnership of NIH, the FDA, 10 pharmaceutical companies, several non-profit organizations, and the Foundation for the National Institutes of Health [1].

  DA: 43 PA: 70 MOZ Rank: 50

• 9. ‘Bespoke Gene Therapy Consortium’ sets out to enable gene

  nature.com

  Link: https://www.nature.com/articles/d41573-021-00193-6

  Description: WEBNov 12, 2021 · The Bespoke Gene Therapy Consortium (BGTC) launched in October to bring together 27 partners to ease the roadblocks to gene therapy development for ultra-rare diseases. The 5-year, US$76...

  DA: 46 PA: 33 MOZ Rank: 62

• 10. NIH, FDA and 15 Private Organizations Join Forces to Increase …

  nih.gov

  Link: https://www.nimh.nih.gov/news/science-news/2021/nih-fda-and-15-private-organizations-join-forces-to-increase-effective-gene-therapies-for-rare-diseases

  Description: WEBOct 29, 2021 · The newly launched Bespoke Gene Therapy Consortium (BGTC), part of the NIH Accelerating Medicines Partnership (AMP) program, aims to optimize and streamline the gene therapy development process to help fill …

  DA: 39 PA: 74 MOZ Rank: 70